poudre pour solution pour perfusion clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Pharmacokinetics of anti-lymphocyte serum in the prevention of GvHD in children and adults receiving allogeneic hematopoietic stem cell transplantation - PHASAL-GA Study
This study looks at how a medicine called Thymoglobuline works in the body of children and adults having a stem cell transplant. We want to see how much of the medicine stays in the blood and for how long. This helps doctors give the right dose to prevent problems.
For: pediatric and adult patients undergoing HSC allograft procedures with Thymoglobulin® packagingFrance - Ongoing, recruitingTherapeutic exploratory (Phase II)
REFRaME-O1: A Phase 2/3 Open-label Study Evaluating the Efficacy and Safety of Luveltamab Tazevibulin (STRO-002) versus Investigator’s Choice (IC) Chemotherapy in Women with Relapsed Platinum-resistant Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing Folate Receptor Alpha (FOLR1)
This study is for women with advanced ovarian (or related) cancer that has come back and isn't responding to platinum-based chemotherapy. Researchers are comparing a new treatment called Luveltamab Tazevibulin with standard chemotherapy to see if it works better and is safe.
For: Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)Austria · Finland · Czechia - Ongoing, recruitingTherapeutic exploratory (Phase II)
AAA-IPC 2011-003 - Prospective and multicentre evaluation of 3 different doses of IV busulfan associated with fludarabine and thymoglobuline in the conditioning of allogeneic stem cell transplantation (SCT) from a matched related or unrelated donor in patients with poor prognosis myeloïd malignancies
This study looks at different doses of chemotherapy drugs to treat serious blood cancers. It aims to see how long patients live without their cancer getting worse after a stem cell transplant from a donor.
For: High-risk myeloïd malignanciesFrance